Diagnostic and Interventional Therapy in Acute Pancreatitis

NCT ID: NCT00699933

Last Updated: 2011-08-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-05-31

Study Completion Date

2012-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study aims to evaluate the course of patients with acute pancreatitis. Thereby we analyze different diagnostics and compare ultrasound, MRI and CT-scan in detection of necrotic areas and evaluate interventional therapy methods like percutaneous drainage techniques regarding the outcome. Laboratory values were assessed as well.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

For laboratory values different inflammation markers were measured and compared.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Pancreatitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Evaluation of one study cohort

CT-guided percutaneous drainage technique

Intervention Type OTHER

Evaluation of different diagnostics and evaluation of outcome of patients who received percutaneous CT-guided drainage for necrotic debridement and analyze the further outcome

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CT-guided percutaneous drainage technique

Evaluation of different diagnostics and evaluation of outcome of patients who received percutaneous CT-guided drainage for necrotic debridement and analyze the further outcome

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age \> 18 years
* Acute pancreatitis
* Written formal consent

Exclusion Criteria

* Pregnancy
* Missing formal consent
* Individual contraindications for CT-scan
* MRI or endoscopic ultrasound
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Regensburg

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

University of Regensburg

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jürgen Schölmerich, Prof.

Role: STUDY_DIRECTOR

Director of Department of Internal Medicine I

Stefan Feuerbach, Prof.

Role: STUDY_DIRECTOR

Director of Department of Radiology

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Internal medicine I, University of Regensburg

Regensburg, , Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Tanja Bruennler, Dr. med.

Role: CONTACT

+49-941-944 ext. 7010

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Tanja Bruennler, Dr. med.

Role: primary

+43-941-944 ext. 7010

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

08/008

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.